Molecular Mechanisms of SGLT2 Inhibitor on Cardiorenal Protection

The development of sodium-glucose transporter 2 inhibitor (SGLT2i) broadens the therapeutic strategies in treating diabetes mellitus. By inhibiting sodium and glucose reabsorption from the proximal tubules, the improvement in insulin resistance and natriuresis improved the cardiovascular mortality i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Yi-Chou, Zheng, Cai-Mei, Yen, Tzung-Hai, Lu, Kuo-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660105/
https://www.ncbi.nlm.nih.gov/pubmed/33105763
http://dx.doi.org/10.3390/ijms21217833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660105/
https://www.ncbi.nlm.nih.gov/pubmed/33105763
http://dx.doi.org/10.3390/ijms21217833

Ejemplares similares